Cliff Asness's DMAC Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 27,451 shares of DiaMedica Therapeutics Inc. (DMAC) worth $188,588, representing 0.00% of the portfolio. First purchased in 2025-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Cliff Asness has initiated a new position in DMAC, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's DiaMedica Therapeutics (DMAC) Holding Value Over Time
Track share changes against reported price movement
Quarterly DiaMedica Therapeutics (DMAC) Trades by Cliff Asness
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2025 | +27,451 | New Buy | 27,451 | $6.87 |
Cliff Asness's DiaMedica Therapeutics Investment FAQs
Cliff Asness first purchased DiaMedica Therapeutics Inc. (DMAC) in Q3 2025, acquiring 27,451 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held DiaMedica Therapeutics Inc. (DMAC) for 1 quarters since Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's largest addition to DiaMedica Therapeutics Inc. (DMAC) was in Q3 2025, adding 27,451 shares worth $188,588. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 27,451 shares of DiaMedica Therapeutics Inc. (DMAC), valued at approximately $188,588. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, DiaMedica Therapeutics Inc. (DMAC) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness's peak holding in DiaMedica Therapeutics Inc. (DMAC) was 27,451 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.